. | Males (n = 93) . | Pre-F (n = 54) . | Post-F (n = 270) . | P . |
---|---|---|---|---|
Age (y) | 58.6 ± 14.5a,b | 40.5 ± 8b | 65.9 ± 8.7 | 0.001 |
Body mass index (kg/m2) | 25.7 ± 4.5a | 22.6 ± 5.7b | 25.7 ± 4.9 | 0.0001 |
Symptomatic (n, %) | 58 (62.3%)b | 35 (64.8%)b | 117 (43.3%) | 0.0005 |
PTH (ng/L) | 121 [148] | 126.5 [96.8] | 139 [137] | 0.955 |
Total serum calcium (mg/dL) | 11.2 ± 1.2 | 11.2 ± 1 | 11.2 ± 1.2 | 0.985 |
Ionized calcium (mmol/L) | 1.5 ± 0.2 | 1.5 ± 0.2 | 1.4 ± 0.2 | 0.639 |
25OHD (µg/L) | 27.9 ± 14.3 | 31.8 ± 21.6 | 28.1 ± 20.3 | 0.560 |
Vitamin D deficiency (%) | 29.8 | 30.5 | 38.9 | 0.27 |
Urinary calcium (mg/24 h) | 278.2 ± 195.3 | 296 ± 175.4 | 241.3 ± 160.5 | 0.080 |
Serum phosphate (mg/dL) | 2.37 ± 0.5b | 2.54 ± 0.6b | 2.71 ± 0.6 | 0.0001 |
eGFR (mL/min/1.73 m2) | 82.9 ± 23.9b | 90.9 ± 22.7b | 76.1 ± 20.5 | 0.0001 |
Presence of kidney stones (n, %) | 47 (50.5%)b | 32 (59.2%)b | 76 (28.1%) | 0.0001 |
Presence of osteitis fibrosa cystica (n, %) | 20 (21.5%) | 7 (12.9%) | 60 (22.2%) | 0.308 |
Distal third-radius T-score | −1.9 ± 1.4a,b | −1.1 ± 1.2b | −2.7 ± 1.6 | 0.0001 |
Lumbar spine T-score | −1.7 ± 1.5b | −1.7 ± 1.3b | −2.7 ± 1.4 | 0.0001 |
Femoral neck T-score | −1.8 ± 1.3b | −1.5 ± 1.2b | −2.2 ± 1.1 | 0.0001 |
Osteoporosis at any site (n, %) | 33 (35.5%)a,b | 10 (18.5%)b | 159 (58.9%) | 0.0004 |
Positive presurgical localization (n, %) | 66 (71%) | 42 (77.7%) | 190 (70.4%) | 0.544 |
. | Males (n = 93) . | Pre-F (n = 54) . | Post-F (n = 270) . | P . |
---|---|---|---|---|
Age (y) | 58.6 ± 14.5a,b | 40.5 ± 8b | 65.9 ± 8.7 | 0.001 |
Body mass index (kg/m2) | 25.7 ± 4.5a | 22.6 ± 5.7b | 25.7 ± 4.9 | 0.0001 |
Symptomatic (n, %) | 58 (62.3%)b | 35 (64.8%)b | 117 (43.3%) | 0.0005 |
PTH (ng/L) | 121 [148] | 126.5 [96.8] | 139 [137] | 0.955 |
Total serum calcium (mg/dL) | 11.2 ± 1.2 | 11.2 ± 1 | 11.2 ± 1.2 | 0.985 |
Ionized calcium (mmol/L) | 1.5 ± 0.2 | 1.5 ± 0.2 | 1.4 ± 0.2 | 0.639 |
25OHD (µg/L) | 27.9 ± 14.3 | 31.8 ± 21.6 | 28.1 ± 20.3 | 0.560 |
Vitamin D deficiency (%) | 29.8 | 30.5 | 38.9 | 0.27 |
Urinary calcium (mg/24 h) | 278.2 ± 195.3 | 296 ± 175.4 | 241.3 ± 160.5 | 0.080 |
Serum phosphate (mg/dL) | 2.37 ± 0.5b | 2.54 ± 0.6b | 2.71 ± 0.6 | 0.0001 |
eGFR (mL/min/1.73 m2) | 82.9 ± 23.9b | 90.9 ± 22.7b | 76.1 ± 20.5 | 0.0001 |
Presence of kidney stones (n, %) | 47 (50.5%)b | 32 (59.2%)b | 76 (28.1%) | 0.0001 |
Presence of osteitis fibrosa cystica (n, %) | 20 (21.5%) | 7 (12.9%) | 60 (22.2%) | 0.308 |
Distal third-radius T-score | −1.9 ± 1.4a,b | −1.1 ± 1.2b | −2.7 ± 1.6 | 0.0001 |
Lumbar spine T-score | −1.7 ± 1.5b | −1.7 ± 1.3b | −2.7 ± 1.4 | 0.0001 |
Femoral neck T-score | −1.8 ± 1.3b | −1.5 ± 1.2b | −2.2 ± 1.1 | 0.0001 |
Osteoporosis at any site (n, %) | 33 (35.5%)a,b | 10 (18.5%)b | 159 (58.9%) | 0.0004 |
Positive presurgical localization (n, %) | 66 (71%) | 42 (77.7%) | 190 (70.4%) | 0.544 |
. | Males (n = 93) . | Pre-F (n = 54) . | Post-F (n = 270) . | P . |
---|---|---|---|---|
Age (y) | 58.6 ± 14.5a,b | 40.5 ± 8b | 65.9 ± 8.7 | 0.001 |
Body mass index (kg/m2) | 25.7 ± 4.5a | 22.6 ± 5.7b | 25.7 ± 4.9 | 0.0001 |
Symptomatic (n, %) | 58 (62.3%)b | 35 (64.8%)b | 117 (43.3%) | 0.0005 |
PTH (ng/L) | 121 [148] | 126.5 [96.8] | 139 [137] | 0.955 |
Total serum calcium (mg/dL) | 11.2 ± 1.2 | 11.2 ± 1 | 11.2 ± 1.2 | 0.985 |
Ionized calcium (mmol/L) | 1.5 ± 0.2 | 1.5 ± 0.2 | 1.4 ± 0.2 | 0.639 |
25OHD (µg/L) | 27.9 ± 14.3 | 31.8 ± 21.6 | 28.1 ± 20.3 | 0.560 |
Vitamin D deficiency (%) | 29.8 | 30.5 | 38.9 | 0.27 |
Urinary calcium (mg/24 h) | 278.2 ± 195.3 | 296 ± 175.4 | 241.3 ± 160.5 | 0.080 |
Serum phosphate (mg/dL) | 2.37 ± 0.5b | 2.54 ± 0.6b | 2.71 ± 0.6 | 0.0001 |
eGFR (mL/min/1.73 m2) | 82.9 ± 23.9b | 90.9 ± 22.7b | 76.1 ± 20.5 | 0.0001 |
Presence of kidney stones (n, %) | 47 (50.5%)b | 32 (59.2%)b | 76 (28.1%) | 0.0001 |
Presence of osteitis fibrosa cystica (n, %) | 20 (21.5%) | 7 (12.9%) | 60 (22.2%) | 0.308 |
Distal third-radius T-score | −1.9 ± 1.4a,b | −1.1 ± 1.2b | −2.7 ± 1.6 | 0.0001 |
Lumbar spine T-score | −1.7 ± 1.5b | −1.7 ± 1.3b | −2.7 ± 1.4 | 0.0001 |
Femoral neck T-score | −1.8 ± 1.3b | −1.5 ± 1.2b | −2.2 ± 1.1 | 0.0001 |
Osteoporosis at any site (n, %) | 33 (35.5%)a,b | 10 (18.5%)b | 159 (58.9%) | 0.0004 |
Positive presurgical localization (n, %) | 66 (71%) | 42 (77.7%) | 190 (70.4%) | 0.544 |
. | Males (n = 93) . | Pre-F (n = 54) . | Post-F (n = 270) . | P . |
---|---|---|---|---|
Age (y) | 58.6 ± 14.5a,b | 40.5 ± 8b | 65.9 ± 8.7 | 0.001 |
Body mass index (kg/m2) | 25.7 ± 4.5a | 22.6 ± 5.7b | 25.7 ± 4.9 | 0.0001 |
Symptomatic (n, %) | 58 (62.3%)b | 35 (64.8%)b | 117 (43.3%) | 0.0005 |
PTH (ng/L) | 121 [148] | 126.5 [96.8] | 139 [137] | 0.955 |
Total serum calcium (mg/dL) | 11.2 ± 1.2 | 11.2 ± 1 | 11.2 ± 1.2 | 0.985 |
Ionized calcium (mmol/L) | 1.5 ± 0.2 | 1.5 ± 0.2 | 1.4 ± 0.2 | 0.639 |
25OHD (µg/L) | 27.9 ± 14.3 | 31.8 ± 21.6 | 28.1 ± 20.3 | 0.560 |
Vitamin D deficiency (%) | 29.8 | 30.5 | 38.9 | 0.27 |
Urinary calcium (mg/24 h) | 278.2 ± 195.3 | 296 ± 175.4 | 241.3 ± 160.5 | 0.080 |
Serum phosphate (mg/dL) | 2.37 ± 0.5b | 2.54 ± 0.6b | 2.71 ± 0.6 | 0.0001 |
eGFR (mL/min/1.73 m2) | 82.9 ± 23.9b | 90.9 ± 22.7b | 76.1 ± 20.5 | 0.0001 |
Presence of kidney stones (n, %) | 47 (50.5%)b | 32 (59.2%)b | 76 (28.1%) | 0.0001 |
Presence of osteitis fibrosa cystica (n, %) | 20 (21.5%) | 7 (12.9%) | 60 (22.2%) | 0.308 |
Distal third-radius T-score | −1.9 ± 1.4a,b | −1.1 ± 1.2b | −2.7 ± 1.6 | 0.0001 |
Lumbar spine T-score | −1.7 ± 1.5b | −1.7 ± 1.3b | −2.7 ± 1.4 | 0.0001 |
Femoral neck T-score | −1.8 ± 1.3b | −1.5 ± 1.2b | −2.2 ± 1.1 | 0.0001 |
Osteoporosis at any site (n, %) | 33 (35.5%)a,b | 10 (18.5%)b | 159 (58.9%) | 0.0004 |
Positive presurgical localization (n, %) | 66 (71%) | 42 (77.7%) | 190 (70.4%) | 0.544 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.